Sam Brusco, Associate Editor01.27.23
Imricor, a developer of real-time interventional cardiac magnetic resonance (iCMR) ablation products, has begun a Memorandum of Understanding (MOU) deal with GE HealthCare.
Under the terms, GE HealthCare and Imricor will partner to interface Imricor’s Advantage-MR EP recorder/stimulator and Northstar-MR 3D mapping system with GE HealthCare MRI scanners. This will allow cardiac electrophysiology (EP) ablation procedures guided with real-time MRI using Imricor’s catheters and other disposable devices on the GE HealthCare MRI platform.
The short-term goal is to permit sites with GE HealthCare MRI systems to enroll in the upcoming “Vision-MR Ablation of Atrial FLutter” or VISABL-AFL clinical trial in the U.S. and “Vision-MR Ablation of Ventricular Tachycardia” or VISABL-VT clinical trial in Europe.
The partnership’s ultimate goal is to expand the choices doctors and hospitals have when selecting an MRI platform for iCMR labs.
“Imricor’s innovative technology has the potential to bring significant benefit to a large number of cardiac arrhythmia patients,” Anja Brau, Ph.D., GM, GE HealthCare MR Clinical Solutions and Research Collaborations, told the press. “GE HealthCare has a long-standing history of applying MR to therapy guidance and control; we would be pleased to add Imricor’s capabilities to provide our customers with more options to treat their patients.”
“We are thrilled at the prospect of expanding the portfolio of MRI scanners that support Advantage-MR and Northstar-MR technology,” added Steve Wedan, Imricor’s CEO and Chair. “The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice, when providing real-time iCMR ablations for their patients. We are grateful to our existing customers who have embraced our real-time iCMR ablation technology, and look forward to making the benefits of this technology even more widely available.”
Under the terms, GE HealthCare and Imricor will partner to interface Imricor’s Advantage-MR EP recorder/stimulator and Northstar-MR 3D mapping system with GE HealthCare MRI scanners. This will allow cardiac electrophysiology (EP) ablation procedures guided with real-time MRI using Imricor’s catheters and other disposable devices on the GE HealthCare MRI platform.
The short-term goal is to permit sites with GE HealthCare MRI systems to enroll in the upcoming “Vision-MR Ablation of Atrial FLutter” or VISABL-AFL clinical trial in the U.S. and “Vision-MR Ablation of Ventricular Tachycardia” or VISABL-VT clinical trial in Europe.
The partnership’s ultimate goal is to expand the choices doctors and hospitals have when selecting an MRI platform for iCMR labs.
“Imricor’s innovative technology has the potential to bring significant benefit to a large number of cardiac arrhythmia patients,” Anja Brau, Ph.D., GM, GE HealthCare MR Clinical Solutions and Research Collaborations, told the press. “GE HealthCare has a long-standing history of applying MR to therapy guidance and control; we would be pleased to add Imricor’s capabilities to provide our customers with more options to treat their patients.”
“We are thrilled at the prospect of expanding the portfolio of MRI scanners that support Advantage-MR and Northstar-MR technology,” added Steve Wedan, Imricor’s CEO and Chair. “The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice, when providing real-time iCMR ablations for their patients. We are grateful to our existing customers who have embraced our real-time iCMR ablation technology, and look forward to making the benefits of this technology even more widely available.”